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Abstract
Background: Generation of novel spontaneous ER positive mammary tumor animal model from
heterozygous NIH nude mice.
Methods: Using brother-sister mating with pedigree expansion system, we derived a colony of
heterozygous breeding females showing ER-Positive tumors around the age of 6 months. Complete blood
picture, differential leukocyte count, and serum levels of Estrogen, Alanine amino transferase (SGPT),
Aspartate amino transferase (SGOT), total protein and albumin were estimated. Aspiration biopsies and
microbiology were carried out. Gross pathology of the tumors and their metastatic potential were
assessed. The tumors were excised and further characterized using histopathology, cytology, electron
microscopy (EM), molecular markers and Mouse mammary Tumor Virus – Long Terminal Repeats (MMTV
LTR) specific RT-PCR.
Results: The tumors originated from 2ndor 5thor both the mammary glands and were multi-nodulated
with variable central necrosis accompanied with an accumulation of inflammatory exudate. Significant
increases in estrogen, SGPT, SGOT and neutrophils levels were noticed. Histopathologically, invasive
nodular masses of pleomorphic tubular neoplastic epithelial cells invaded fibro-vascular stroma, adjacent
dermis and subcutaneous tissue. Metastatic spread through hematogenous and regional lymph nodes, into
liver, lungs, spleen, heart and dermal lymphatics was observed. EM picture revealed no viral particles and
MMTV-negativity was confirmed through MMTV LTR-specific RT-PCR. High expression of ER α,
moderate to high expression of proliferating cell nuclear antigen (PCNA), moderate expression of
vimentin and Cytokeratin 19 (K19) and low expression of p53 were observed in tumor sections, when
compared with that of the normal mammary gland.
Conclusion: Since 75% of human breast cancer were classified ER-positive and as our model mimics (in
most of the characteristics, such as histopathology, metastasis, high estrogen levels) the ER-positive luminal
epithelial-like human breast cancer, this model will be an attractive tool to understand the biology of
estrogen-dependant breast cancer in women. To our knowledge, this is the first report of a spontaneous
mammary model displaying regional lymph node involvement with both hematogenous and lymphatic
spread to liver, lung, heart, spleen and lymph nodes.
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Breast cancer is the most common malignancy in women
and the mortality rate has been continuously increasing
over the past 30 years. Based on ER level, about 70% of
human breast cancers are phenotyped as ER-positive and
others as ER-negative. Recently, micro-array studies have
corroborated that majority (65%) of breast tumors are
'luminal epithelial-like/ER-positive' subtype, which
express high levels of ERα and genes regulated by estrogen
[1]
Mouse models are excellent tools to understand the natu-
ral biology of breast cancer. Since human breast cancers
are clustered into several phenotypes (subtypes) based on
grade, molecular-markers and micro-array studies, a good
animal model for a subtype is one which mimics most of
the subtype characteristics – morphology, molecular
markers, metastatic pattern, grade, hormone-dependency,
parity/pregnancy-status etc. [2,3]. Mouse tumors show a
hematogenous spread almost exclusively to the lung, in
contrast to human tumors, which show regional lymph
node involvement with preferential spread to bone, brain,
liver and heart. Also in mice, ER-positive and hormone-
dependant mammary tumor is rare, where as this tumor
subtype is found in majority(70%) of the human breast
cancers [2,4] Recently, though there is a continuous
arrival of new GEM models, it seems difficult to develop a
'high' similar mouse model of ER-positive and high-estro-
gen human breast cancer. [3,4].
We here report the development of ER-positive high-
estrogen mammary tumor animal model from a sponta-
neously mutated NIH nude heterozygous female mice
and the characterization based on histological, ultra struc-
tural, cellular and molecular approaches. At Present, there
are almost no spontaneous or induced or genetically engi-
neered mouse model available to study both hematoge-
nous and regional lymph node dissemination with
involvement of liver, spleen, heart and lungs even though
it is the most frequent mode of dissemination for human
breast cancer. To our knowledge, this is the first report of
a mouse model showing metastasis both through hema-
togenous and lymphatic route.
Methods
Selection and propagation of tumor mice
In NIH nude mouse colony at animal house, Centre for
Cellular and Molecular Biology (CCMB), we detected
mammary tumors in one of the heterozygous breeding
females. The tumor mouse was used as founder and con-
tinuous brother-sister mating with pedigree expansion
system was followed to develop a medium-size hetero-
zygous breeding colony showing high incidence of mam-
mary tumors. F1 generation of brother sister mating
produced offspring of 1/4 nu/nu (homozygous nude) ; 2/
4 +/nu (heterozygous) and 1/4 +/+ mice. Wild type (+/+)
and nu/nu mice does not show tumor. (0%) in their
entire life span.
The animals were housed in accordance with the guide-
lines for care and use of animals in scientific research
(Indian National Science Academy, New Delhi, India) in
a CPCSEA (Committee for the purpose of control and
supervision of experiment on animals) registered animal
facility. The animals were maintained in Cabin type isola-
tors at standard environmental condition (Temperature
22 – 25°C, Humidity 40 – 70%) with 12:12 dark/light
photoperiod. No precise quantitative guidelines such as
the acceptable upper limit of tumor burden was available,
since the adverse effects on the host depend on the biol-
ogy of the tumor, the site and mode of growth. But, we
euthanized the mice before the size of tumor reached 10%
of the animal's body weight.
Tumor cytology & microbiology
Fine needle aspiration biopsy (FNAC) was taken from
tumors and smears were prepared. The animals were euth-
anized and impression smears were made from the
excised tumors. The Smears were air-dried, methanol-
fixed, Giemsa-stained, and the images were captured
under Zeiss axioplan microscope. 50 µl of tumor aspirate
was transferred to 5 ml of nutrient broth (Himedia Labo-
ratories, India) and the samples were kept at 37°C over
night. Samples showing turbidity were streaked in Nutri-
ent agar plates (Himedia Laboratories, India) and incu-
bated at 37°C overnight. The colonies were stained with
Gram stain and also streaked into blood agar and Manni-
tol salt agar plates (37°C). When colonies appeared, coag-
ulase test was done.
Hematological and biochemical assays
Body weight and tumor size were measured during initial
stage of tumor progression, and at the time of sacrifice of
animals to all the tumor-bearing animals (26 numbers)
and normal animals (16 number). Complete blood pic-
ture [(Hemoglobin (Hb), Packed cell volume (PCV),
Erythrocyte sediment rate (ESR), Red blood cells (RBC),
White blood cells (WBC)] and differential leukocyte
count were observed in all the tumor and normal animals
as per standard procedure. Serum samples were analyzed
for total protein, SGOT and SGPT by standard method
using autoanalyser (autoanalyser2004 Bayer,). Serum
estrogen and progesterone levels were measured by elec-
trochemiluminescence immunoassay (Elecsys 1010/2010
and modular analytics E170 immunoassay analyzers,
Roche Diagnostics, USA). Blood glucose levels were esti-
mated by using digital AccuCheck sensor (Roche Diagnos-
tics, USA).Page 2 of 12
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Complete gross and histopathological evaluations were
done. After euthanasia, mammary tumors and all organs
were collected in 10% buffered Formalin (Liver, lungs,
kidneys, heart, spleen, brain, pancreas, lymph node,
bone, salivary gland, adrenals, small and large intestine,
uterus, ovary, cervix and urinary bladder). Fixed and par-
affin embedded tissues were cut at 5 µm thickness, stained
with haematoxylin and eosin following standard proce-
dure and examined under light microscope.
Electron microcopy
Tumor tissues were fixed in 10% glutaraldehyde and then
with 1% osmium tetraoxide in 0.1 M phosphate buffer,
dehydrated in graded solutions of ethanol and embedded
in LX – 112 (Fullium). Thin sections were stained with 1%
Azur II plus 1% methylene blue in water for 3–5 min and
then examined under light microscope. Ultramicrotome
sections, contrasted with uranyl acetate and lead citrate
were examined and photographed by transmission elec-
tron microscope (JEM-3100F TEM, JEOL Ltd, Japan). The
sections were screened for MMTV and tumor cell mor-
phology.
Immunoflouresence assay using confocal microscopy
The level of expression of ER α, K18, K19, Vimentin,
PCNA, p53, integrin α and Wnt-1, p63 were checked
using immunofluorescence assay. Briefly, frozen section
(16 µm) of tumor samples and normal mammary gland
(control) were fixed with acetone for 20 minutes followed
by permeabilization with 0.5% (v/v) Triton × 100 in PBS
for 10 minutes at room temperature. After blocking with
5% horse serum in PBS for 1 hour, the sections were incu-
bated with primary antibody for 1 hour and then incu-
bated with FITC conjugated secondary antibody for 1
hour at room temperature. To reduce autofluorescence,
the sections were treated with CuSO4 (10 mM) in ammo-
nium acetate buffer (50 mM CH3COONH4, pH 5.5) for
30 minutes. The sections were counterstained with pro-
pidium iodide (PI) for 5 minutes and mounted in vector
shield (Vector laboratories). The normal and tumor sec-
tions treated as above, but without primary antibody,
served as negative controls. Lung and liver of tumor ani-
mals were also screened for the expression of ER α. The
primary antibodies used were mouse monoclonal anti-
bodies to ER α, (Catalog number – SC787; Santa Cruz
Biotechnology, USA), Cytokeratins K18, K19, Vimentin,
PCNA, p53, integrin α 5 and Wnt-1 (Santa Cruz Biotech-
nology, USA) and p63 (Chemicon International). Confo-
cal laser scanning immunofluorescence microscopy
(CLSM) was carried out using a Zeiss LSM 510 META con-
focal microscope. Image analysis was done using LSM510
META software (Carl Zeiss) and images were assembled
using adobe Photoshop 7.0.
RT-PCR with MMTV specific primers
RNA were isolated from tumor of NIH heterozygous mice
and mammary gland of normal NIH nude heterozygous
mice, normal inbred c57BL/6 J and c3H/HeJ mice using
TRIZOL Kit (GIBCO-BRL) according to the instruction
provided by the supplier. Each RNA sample was subjected
to RT-PCR with MMTV LTR-specific primers FPC1
5'GACATGAAACAACAGGTACATGA3' and RP 5'GGACT-
GTTGCAAGTTTACTC 3' based on a standard procedure
[5]. Genomic DNA were isolated from tumor mice and
inbred mice (c57BL/6 j and c3H/he J mice) tail as positive
control using phenol chloroform method. Genomic DNA
were amplified with MMTV LTR specific primer. Addition
to this, CDNA from tumor was amplified with beta actin
primer (βactin432F 5' GCG TGA CAT CAA GGA GAA GC
3' and βactin432R 5' TGG AAG GTG GAC AGG GAG GC
3') as a positive control.
Hormone responsiveness of mammary tumor
We selected six tumor bearing animals for ovarioectomy
study and among this animal number 42, 46 and 47 as
treated group and rest of the three as positive control. The
animal was anesthetized using Ketamine (40 mg/kg body
weight) and Xylazine (10 mg/kg body weight) through
intraperitoneal injection and Overectomy was done in
bilateral as per standard guideline for rodent surgery.
Tumor volume and pre operative serum estrogen and pro-
gesterone were measured by chemiluminescence's immu-
noassay. Serum estrogen, progesterone levels and tumor
volume were also checked for every seventh day from the
day of removal of ovary to 28 days from all the six ani-
mals. Tumor Volume was calculated by using standard
formula made earlier [V = 0.4(ab2); a – length of the
tumor; b – height and width of the tumor] [6].
Results
Animals
Mammary tumors were observed only in female breeding-
mice, mostly after delivering the second litter. The females
which were not mated did not develop tumors in its life
span. Among 42 females bred, 26 females developed
mammary adenocarcinoma (incidence rate 62%). The age
of occurrence of tumor was about 7 months (range, 3.5 to
12 months). The tumors were unilateral i.e., developed
either in right or left side mammary glands and were
observed only in 2nd or 5th or both mammary glands (Fig.
1). The tumor grew rapidly and reached 10% of the body
weight in 3–5 weeks. At the time of euthanasia, the aver-
age body weight was about 33 gm and the tumor-size was
about 3 cm × 3 cm × 2 cm (l × w × h).
Tumor cytology & microbiology
Smears showed low to moderate cellularity. Small to large
clusters of loosely cohesive cells with hyper chromatic
nucleus were found. Tumor cells were pleomorphic. ThePage 3 of 12
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small to giant sized with normal or foamy cytoplasm and
eccentric or centrally placed nucleus. (Fig. 2). Golden-pig-
mented colonies were seen in mannitol salt agar. Smears
showed gram-positive grape-like clusters of organisms.
Colonies were coagulase positive suggestive of Staphyloco-
ccus aureus.
Hematological and biochemical assay
Mean ± SE values of various hematological and biochem-
ical parameters were displayed in Table 1. While compar-
ing with normal control, the level of RBC was low and the
levels of neutrophils, estrogen, SGPT and SGOT were
high.
Histopathological analysis
Neoplastic mass, while it reaching 1/10th body weight,
appeared as multi-lobes with ulceration on the skin sur-
face. On palpation, fluid thrills were observed in each
lobe. Exteriorized tumor mass revealed multi-lobes, each
lobe had multiple solid nodules enclosing a central
necrosed tissue with foul smelling inflammatory exudate
and clotted blood. Multiple pinkish metastatic nodules
were observed in all the lobes of lungs. (Fig 3) lung nod-
ules varied from 0.7 × 0. 5 × 0.3 cm to 0.3 × 0.25 × 0.15
cm. Splenomegaly with multiple white colored nodules
popping out from inner splenic parenchyma were
observed. Liver and peripheral lymph nodes were
enlarged in all the animals.
Histologically, the expansile tumor mass pushed through
the overlying dermis and was found infiltrating the mus-
cle layer underlying the mammary gland. The tumor mass
resembled luminal/tubular epithelial-like morphology
with well differentiated (Grade 1) lobes. Each lobe had
lobules showing acinar or cystic or combination of acinar,
cystic and inflammatory patterns. (Fig. 4). The tubules
were lined by single or multiple layers of pleomorphic
epithelial cells. Some region of the tubules were filled
with amorphous inflammatory exudate appeared as cystic
pattern. The neoplastic epithelial cell had indistinct bor-
ders and contained scant to moderate amount of cyto-
plasm with pleomorphic nucleus with mitotic figures.
Multiple area of necrosis with infiltration of neutrophils
appeared in between and within lobules.
Neoplastic tubular epithelial cells metastasized into
lungs, liver, spleen, lymph node, heart, dermal lymphatic
vessels and sebaceous gland (Fig 5). No metastatic foci in
bone, salivary glands, adrenal, kidney, brain, intestines,
and pancreas were detected. Entire alveolar region of
lungs were occupied by multiple lobes of tubular neoplas-
tic cells. The morphology of lung tumors was similar to
that of mammary tumors. Multiple foci of tumor emboli
consisting of pleomorphic neoplastic cells spreading
through hepatic sinusoids were found in liver. Large sized
pleomorphic neoplastic cells were found in splenic and
lymphatic follicles. Nodular-type tumors consisting of
pleomorphic tubular epithelial cells were found attached
to inner wall of aorta. Pleomorphism, moderate differen-
tiation and loss of polarity in sebaceous glands were sug-
gestive of metastatic invasion. Few necrotic foci and sparse
distribution of individual pleomorphic cells in cerebral
hemisphere were observed.
Ultra structure
Electron microscopic picture revealed round to oval
shaped dark epithelial cells Large numbers of endoplas-
mic reticulum and secretory granules were observed in the
cells (Fig 6). Increase in endoplasmic reticulum indicated
higher metabolic activity, protein and lipid synthesis in
the cells. None of the sections showed myoepithelial cells
and MMTV virus particles. Euchromatin was predomi-
nantly observed inside the nuclear membrane. The pre-
dominance of euchromatin is attributable to the high
percentage of cells in DNA synthesis phase (S phase) and
this is usually seen in cancerous cells.
Confocal microscopy
High expression level of ER α was found in neoplastic epi-
thelial cells of all the tumor sections when compared with
normal mammary gland controls. Expression of K18 and
K 19 were high in neoplastic epithelial cells. Higher
expression of vimentin in stromal cells and also poly-
morph nuclear cells and mononuclear cells, which were
frequently found within the lobes of tumor strongly,
reacted with vimentin antibodies. Low expression of p53,
mild to moderate expression of p63 and moderate to high
expression of PCNA in neoplastic epithelial cells were
Biparous heterozygous NIH nude females showing mammary tumorsF gure 1
Biparous heterozygous NIH nude females showing mammary 
tumors.Page 4 of 12
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Fine needle aspiration Cytologyigur  2
Fine needle aspiration Cytology. A. A small cluster of spindle and round cells with pleomorphic nuclei. B. A medium sized 
cluster with loosely cohesive round cells with hyper chromatic nucleus. C&D. A Large cluster with very loosely cohesive signet 
ring cells with eccentric, hyperchromatic, pleomorphic nuclei. E&F A large cluster with loosely cohesive round to polygonal 
foamy cells with hyperchromatic nuclei. G. Giant-sized foamy cells with eccentric nuclei. H. Giant binucleated foamy cell. Mag-
nification (Giemsa, × 100).
BMC Cancer 2007, 7:180 http://www.biomedcentral.com/1471-2407/7/180seen. (Fig 7). Wnt-1 and integrin α 5 were not expressed.
No immunofluorescence was observed in the negative
controls.
MMTV LTR-specific RT-PCR
PCR using MMTV LTR-Specific primers (FPC1& RP) with
cDNA template from tumor tissue, RNA from inbred mice
did not show any amplification, but genomic DNA of
inbred mice c57BL/6 J and c3H (positive control) showed
amplification of 426 bp. PCR using βactin primers with
CDNA template from tumor tissue showed amplification
of 432 bp. (Fig 8). These results indicate MMTV negativity
in our animal model.
Hormone responsiveness of mammary tumor
Detailed hormone responsiveness has been displayed in
Table 2 &3. Estrogen and progesterone and tumor size
were reduced from seventh days onwards. No serum estro-
gen and progesterone were observed on and after 14 days.
Tumor size was gradually reduced from seventh days
onwards and on 28 th day tumor size was reduced to more
than half the size of the tumor on day 1.
Discussion
We have developed a spontaneous mammary tumor
model with high level of ER expression along with high
levels of serum estrogen. The model displayed metastasis,
through both hematogenous and lymphatic route, into
regional lymph nodes, liver, lung, heart, spleen and
lymph nodes. The tumors predominantly had luminal/
tubular epithelial-like morphology. All the above charac-
teristics make the model resemble closely to the ER-posi-
tive, luminal epithelial- like subtype of human breast
cancer.
High levels of endogenous sex steroid hormones are asso-
ciated with increased risks of breast cancer in postmeno-
pausal women and levels of circulating estrogens and
androgens may be important in the etiology of premeno-
pausal breast cancer [7]. Most of the study disseminated
the information that steroid and peptide hormones have
a considerable effect on the initiation of mammary tum-
origenesis [8]. Rat models are found to be better than
mouse models for study of estrogen signaling and tumor-
igenesis in vivo, since they show high frequency of ER-
positive lesions [8]. Ironically, the techniques for targeted
manipulation of rat genome is in the developmental stage
[3] and rats predominantly show fibroadenoma rather
than adenocarcinoma mammary tumors [9]. In contrast
Table 1: Significant increase in estrogen and liver enzyme
Parameters Tumor mice (Mean ± SE) Normal Value (Range)
Age of Tumor Incidence 7.2 ± 0.4 months -
Body Weight 33.5 ± 0.68 g 29.6 ± 0.68 g
Glucose 111 ± 1.9 mg/dl 126 ± 1.9 g/dl
Hemoglobin 13 ± 0.2 g/dl 11.6 g ± 0.12 g/dl
RBC 4.7 ± 0.08 × 106 8.6 ± 0.14 × 106
WBC 9650 ± 93/mm3 3250 ± 12/mm3
Neutrophils 60.5 ± 0.4% 32 ± 0.28%
Lymphocytes 37.4 ± 0.3% 48 ± 0.16%
Eosinophils 1.8 ± 0.17% 1.6 ± 0.13%
Estrogen 15.1 ± 0.22 pg/ml 1.2 ± 0.13 pg/ml
Progesterone 0.13 ± 0.006 ng/ml 0.1 ± 0.04 ng/ml
SGPT 58.2 ± 1.2 IU/L 23 ± 2.6 IU/L
SGOT 70.3 ± 0.66 IU/L 28 ± 1.2 IU/L
Albumin 3.34 ± 0.04 g/dl 3.2 ± 0.07 g/dl
Total Protein 6.65 ± 0.04 g/dl 5.2 ± 0.12 g/dl
Metastasis in LungsFigure 3
Metastasis in Lungs.Page 6 of 12
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hormone – independent mammary tumors [4].
Majority of human breast cancers (75%) are ER positive,
[10] but vast majority of mammary lesions in GEM are ER
– negative. To our knowledge, few GEM ER + animal
model have been made [11-15] in the recent past. But,
most GEM does not precisely recapitulate steroid receptor
signaling during neoplastic transformation.
In chemically induced tumor model, medroxyprogester-
one produced mammary adenocarcinoma in balb/c mice
possess estrogen and/or progesterone, PRL, and EGF
receptors was reported earlier [16,17]. Traditional models
and recent data from genetically engineered mouse
(GEM) models suggest many similarities between mam-
mary cancers of mice and human at gene/pathway-level,
but important differences in the biology of metastasis and
the preponderance of ER- positivity and hormone-
dependency [3,4]. Presently xenograft models are used in
preclinical studies. But these models are immunocompro-
mised and are unable to express the steroid hormones at
the near-physiological levels. This makes the model inap-
propriate for studies on immunotherapy, anti-hormonal
therapy. Also, Xenograft model needs human stromal
cells to be co-transplanted with human epithelial cells to
provide local growth factors needed for epithelial tumor
growth. Though the human epithelial cells would metas-
tasize lung or bone, they will only interact with murine
stroma. In therapeutic studies, targeting stroma of metas-
tasizing breast cancer would be inadequate in xenografts
models using tissue-recombination approaches. In this
context, our immunocompetant models (heterozygous
nude females) showing high serum estrogen mimicking
their human counterparts should be useful for immuno-
therapy and anti-hormonal therapy studies.
MMTV was incriminated for most of the mammary
tumors in mice. MMTV exists as both an endogenous and
exogenous virus transmitted to pups via the germ line and
breast milk. All inbred strain of mice as well as some wild
mice contain multiple copies of MMTV proviral inte-
grants, although most of them fail to produce infectious
MMTV particle. (5). The virus does not contain oncogene
but inserts near known sets of proto-oncogenes resulting
in up regulation and tumorigenesis [18]. MMTV infection
activates the notch, Wnt and FGF family genes. Wnt -1 was
discovered as a gene frequently activated in mammary
tumor arising in mice infected with MMTV [19]. In our
model, electron microscopic picture of mammary tumor
revealed no viral like particles, immunofluorescence assay
showed that expression level of Wnt – 1 was not different
from that of normal controls. The RT-PCR results further
corroborates MMTV negativity in our models. Previous
studies show that correlation between activation of Wnt-1
Tumor morphologyFigure 4
Tumor morphology. A&B. Luminal/tubular epithelial-like 
morphology. Tubules lined by single or multiple layers of ple-
omorphic epithelial cells. (arrow) (A-H&E, ×200 ; B- H&E, × 
400). C. Lobules separated by stroma (arrow). H&E, ×100 
D.A lobule surrounded by stoma (arrow). H&E, ×200. E&F. 
Tumor mass pushing the adjacent dermis, H&E, ×200.G&H. 
Neutrophils invading the necrosed areas in the tumor mass 
(arrow). H&E, ×200. I&J. Neoplastic epithelial cells with 
hyperchromatic nucleus invading the underlying muscle lay-
ers (arrow)(I-H&E, ×100; J- H&E, × 200).Page 7 of 12
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Tumor MetastasisFigure 5
Tumor Metastasis. 1 & 2. Metastatic foci in lungs showing luminal epithelial-like morphology as in primary with well differen-
tiated secretory glands (1-H&E, ×100 ; 2- H&E, × 200).3 & 4. Metastatic foci in liver. (arrow)- 3 -H&E, ×200 ; 4- H&E, × 400).5 
& 6. Metastatic nodules growing on the vascular endothelium of aorta (5-H&E, ×100 ; 6- H&E, × 200). 7 & 8 Sebaceous glands 
showing pleomorphism, moderate differentiation and loss of polarity (arrow) (7-H&E, ×200 ; 8- H&E, × 200).
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Electron microscopy of tumor sectionFigu e 6
Electron microscopy of tumor section. A&B : High number of endoplasmic reticulam in the tumor epithelial cells. No 
viral-like particles detected. Magnification × 6000.
Immunoflouresence assayFigure 7
Immunoflouresence assay: Intensity of Greenfluorescence indicates the expression level of the correspondingmolecular markers. A, B, C – Normal 
mammary gland section of respectivemarker; D, E, F – Tumor section of respective marker. Magnification ×1000. A – FITC alone; B – PI alone; C – Dual 
(FITC & PI). D -FITC alone; E – PI alone; F – Dual (FITC & PI). ER: Higher expression inneoplastic epithelial cells (F) than normal controls(C). P53: Low-
erexpression in neoplastic epithelial cells (F) than normal controls C. PCNA: Moderate to higher expression in neoplastic epithelial cells (F) than normal 
controls(C). K19: Moderate expression in neoplastic epithelial cells (F) than normal controls(C). Vimentin: High expression of vimentin in the stromal cells 
(F) than normal controls (C).
BMC Cancer 2007, 7:180 http://www.biomedcentral.com/1471-2407/7/180and ER positivity could not be established in mouse mod-
els. For example, estrogen receptor positivity in mammary
tumors of wnt – 1 transgenic mice is influenced by collab-
orating oncogenic mutations rather than wnt-1 per se [9].
Mouse mammary tumor virus-Wnt-1 transgene also
induced mammary gland hyperplasia and tumorigenesis
in mice lacking estrogen receptor-alpha, though it is not
known whether ER signaling is necessary for survival of
the ER + tumors that develop in Wnt-1 TG mice [9]. Also,
no positive correlation between MMTV viral sequence and
estrogen receptor positivity in human breast cancer was
reported earlier [20].
Aspiration biopsy, tumor cells were arranged in clusters
and dissociation with spindle, binucleated, round to pol-
yhedral clusters and foamy clusters of signet ring shaped
cells. The same kind of cytological observations were
reported earlier with FNAC [21] in human breast cancer.
Microbiological examination confirmed the tumor mass
infected with Staphylococcus aureus. The presence of bac-
teria might be due to secondary invasion.
High estrogen levels correlated with higher expression
pattern of ER and also increased levels of SGPT, SGOT
indicative of liver damage due to metastasis or tumor
emboli. Higher the levels of neutrophils support the
inflammation and necrosis between the lobes of tumor
mass. Overectomy experiment indicates that, our animal
model has responded to ovarian hormone and majority
of ER + tumors respond to antiestrogen therapies despite
their high or low levels of ER expression [22]. We could
not interpret the hormone responsiveness based on three
ovarioectomy mice. We require lot of further experiments
(antiestrogenic therapy with tamoxifen, replacing estro-
gen levels with pellet) with more number of animals.
Our model shows both hematogenous and regional
lymph node dissemination with involvement of liver,
spleen, heart and lungs. But, human breast cancers com-
monly metastasize into regional lymph nodes. The reason
for metastasis into regional lymphnodes in this mouse
model is still unclear. This might be due to aggressive
growth or high cell number due to increased tumor bur-
den. Mammary tumor manipulation induced dissemina-
tion to the axillary nodes and increased up to 6-fold the
number of metastatic lung nodules [23]. The average per-
centages of lymph node metastasis in mouse inoculated
with mouse hepatocellular carcinoma Hca-F cells
increased in an almost proportional fashion with the
number of cells implanted subcutaneously [24]. More
future studies are needed to explain the regional lymph
node involvement in mouse models since there are basic
differences between human and mouse mammary tissue
in epithelium-stroma microenvironment.
Conclusion
Metastasis rather than primary tumor are responsible for
most breast cancer related to deaths in human. Since our
model mimics most of the characteristics of the
major(70%) human breast cancer subtype(Luminal epi-
thelial-like/ER positive) and shows metastasis into
regional lymph nodes and distant organs, we believe this
Table 2: Hormone responsiveness in tumor mice
Serum Estrogen pg/ml in days Serum Progesterone ng/ml in days
0 7 14 21 28 0 7 14 21 28
An. No O/P O P O P O P O P O P O P O P O P O P O P
42/01 12.2 1.2 0.5 0.9 - 0.9 - 1.2 - 1.2 0.1 0.08 0.03 0.1 - 0.07 - 0.08 - 0.08
46/02 16.5 0.9 0.3 0.8 - 1.3 - 1.2 - 0.8 0.2 0.09 0.02 0.12 - 0.08 - 0.09 - 0.09
47/03 14.7 0.7 0.4 0.7 - 0.8 - 1.2 - 1.2 0.1 0.08 0.06 0.08 - 1.2 - 0.09 - 1.1
O – Overectomized tumor animals; P – Positive control of tumor animals
MMTV screening with RT-PCRFigure 8
MMTV screening with RT-PCR. Lane 1 & 10 -100 bp 
laddar; 2 & 3 – CDNA from tumor sample; 4 & 5 Genomic 
DNA of C57 and C3H mice (426 bp); 6 & 7 – RNA from c57 
and c3H mice; 8 & 9 – CDNA from tumor sample with β 
actin primers (432 bp).Page 10 of 12
(page number not for citation purposes)
BMC Cancer 2007, 7:180 http://www.biomedcentral.com/1471-2407/7/180has a major application potential in the human breast
cancer studies.
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